companydata.dkcompanydata.dk

EP MEDICAL ApS: Financial statements 2023

CVR: 29631905

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

EP MEDICAL ApS (CVR 29631905) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 300,195 and a net result of DKK 103,849 compared with DKK -1,071,536 the year before. That is a decrease of 3.2% compared with the year before. The profit margin was 34.6%. Equity in the 2023 report amounted to DKK 6,208,041. The solvency ratio was 98.7%. The company had 1 employee in the financial year.

Revenue
DKK 300,195
Gross Profit
DKK 97,406
Profit/Loss
DKK 103,849
Equity
DKK 6,208,041
Total Assets
DKK 6,288,264
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023300K97K104K6.2M1
2022310K144K-1.1M6.2M1
2021300K175K299K7.4M1
2020369K268K-101K7.2M1
2019804K605K856K7.4M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

EP MEDICAL ApS: The 2022 annual report is outFeb 17, 2023

EP MEDICAL ApS has published its annual report for 2022. Revenue came to DKK 309,997, and the net result was DKK -1,071,536.

About EP MEDICAL ApS

EP MEDICAL ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named EP MEDICAL CONSULTING ApS and REFLAB HOLDING ApS. The management consists of Eva Valbjørn Sørensen. The company is owned by Per Stahl Skov and Eva Valbjørn Sørensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 265,299 and a net result of DKK -348,750 compared with DKK 182,500 the year before. Equity in the 2025 report amounted to DKK 5,784,791.

Source: annual report 2025, Danish Business Authority